Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    11042984 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Efficacy of Buffered Lidocaine in Patients With Facial Swelling
Condition: Facial Swelling
Interventions: Drug: 4% lidocaine with 1:100,000 epinephrine;   Drug: 4% buffered lidocaine with 1:100,000 epinephrine

Indicates status has not been verified in more than two years